USD92.58 ₽ EUR100.28 ₽ telegram Telegram
Brainstorm Cell Therapeutics  logo
Brainstorm Cell Therapeutics BCLI
$ 0.37 -1.6%

Brainstorm Cell Therapeutics Мультипликаторы 2011-2024 | BCLI

Мультипликаторы по годам Brainstorm Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.9 -2.8 -5.9 -5.9 -3.8 -5.3 -13.7 -10.3 -5.4 -5.9 -8.9 -9.2 -6.7

P/S

- - - - - - - - - - - - -

EPS

-0.4 -0.7 -0.7 -1.1 -1.1 -0.7 - - - - - - -

EV (Enterprise Value)

39.6 млн 77.5 млн 136 млн 166 млн 106 млн 78.9 млн 70.7 млн 51.6 млн 48 млн 53.5 млн 42 млн 31.7 млн 25.8 млн

EBITDA per Share

-0.49 -0.67 -0.67 -1.01 -1.04 -0.698 -0.262 -0.268 -0.464 -0.543 -0.467 -0.384 -0.467

EV/EBITDA

-5.6 -4.8 -3.8 -5.2 -13.3 -10.1 -5.3 -6.8 -8.0 -8.6 -6.5

PEG

0.65 -0.08 -0.17 0.16 0.07 0.03 -3.69 -0.25 -0.17 0.12 0.18 -0.28 2.32

P/B

-6.6 -22.2 7.5 5.3 -7.2 14.7 11.5 5.2 3.2 8.2 15.9 7.9 17.8

P/CF

-1.6 -3.5 -5.5 -5.3 -7.5 -5.8 -26.6 -8.6 -6.1 -11.7 -10.4 -10.5 -11.6

ROE %

353.89 805.21 -126.45 -89.70 190.24 -278.07 -84.22 -50.31 -60.08 -138.52 -178.86 -86.14 -263.31

ROA %

-408.56 -287.27 -83.54 -62.06 -355.88 -124.23 -43.35 -46.28 -49.70 -93.29 -103.66 -64.60 -142.78

ROCE %

596.85 7112.32 -106.88 -79.16 206.84 -280.36 -85.02 -51.33 -60.42 -109.16 -147.85 -84.34 -242.01

Current Ratio

0.5 0.7 2.9 3.8 0.2 1.7 1.7 12.1 5.7 3.1 3.3 4.3 2.0

DSO

- - - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Brainstorm Cell Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.03 -0.13 -0.14 - -0.19 -0.19 -0.15 - -0.15 -0.17 -0.19 - -0.14 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

-0.13 -0.14 -0.14 - -0.19 -0.21 -0.15 - -0.14 -0.17 -0.19 - -0.14 -0.25 -0.29 - -0.25 -0.22 -0.23 - -0.15 -0.16 -0.12 - -0.13 -0.06 -0.09 - -0.09 -0.05 -0.1 - -0.14 -0.13 -0.12 - -0.16 -0.1 -0.18 - -0.1 -0.01 -0.01 - -0.01 -0.01 -0.01 - -0.01 0.01 0.01

ROE %

-204.81 -746.39 -973.34 -620.77 -642.18 -169.50 -100.59 -60.59 -73.24 -64.49 -64.56 -56.38 -10.29 48.46 259.55 426.57 148.50 -175.66 -643.97 -834.21 -918.43 -724.58 -530.72 -252.65 -302.97 -269.06 -235.16 -150.94 -211.02 -220.78 -230.55 -180.24 -318.75 -397.19 -475.63 -415.55 -594.41 -634.76 -675.10 -536.58 -622.72 -530.00 -437.27 -258.41 -521.72 -698.89 -876.06 -789.92 -263.31 -263.31 -263.31

ROA %

-230.31 -260.48 -204.89 -109.66 -125.11 -88.82 -66.52 -44.01 -52.76 -46.07 -45.65 -39.01 -125.24 -202.71 -544.16 -797.98 -922.20 -960.20 -728.55 -372.68 -416.03 -335.15 -254.28 -130.05 -176.33 -179.25 -182.18 -138.83 -188.52 -191.94 -195.36 -149.09 -242.38 -285.97 -329.57 -279.87 -383.53 -393.90 -404.27 -310.98 -375.58 -336.51 -297.45 -193.79 -336.57 -414.76 -492.95 -428.35 -142.78 -142.78 -142.78

ROCE %

1267.87 164.56 -184.04 -256.89 -275.28 -134.80 -84.42 -53.46 -64.67 -57.48 -58.06 -50.45 -0.53 60.59 122.76 137.91 73.48 -40.87 -146.09 -171.97 -212.65 -188.90 -145.64 -89.06 -105.61 -81.47 -73.11 -44.77 -62.97 -64.62 -71.42 -50.53 -86.28 -103.82 -106.13 -85.83 -117.68 -113.79 -138.95 -107.93 -136.81 -133.84 -110.46 -71.50 -118.14 -135.90 -41.69 74.13 -46.64 73.39 47.38

Current Ratio

0.7 0.6 0.6 0.7 1.1 1.7 2.3 3.0 3.6 3.5 3.9 3.2 3.2 3.2 3.2 0.3 0.3 0.3 0.3 1.8 1.8 1.8 1.8 2.1 2.1 2.1 2.1 12.5 - - - 5.8 6.0 6.8 6.3 3.1 3.1 3.1 3.1 2.4 2.4 2.4 2.4 4.4 4.0 4.0 4.0 2.2 2.2 2.2 2.2

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD